The Thoracic Oncology Program Area is composed of 16 members, spanning 11 Departments within UCLA. In the past competing cycle, investigators from this Program authored 179 publications, of which 81 (45%) were inter-programmatic and 107 (60%) intra-programmatic. 58 (32%) were placed in high-impact journals. 10 members of this Program Area used 5 out of the 8 currently funded JCCC Shared Resources. Current peer-reviewed funding for this program totals $3.2M of which $2.1M is awarded from NCI. The JCCC has provided the Thoracic Oncology Program with ~$1.9M in support of its members and activities. These funds supported seed grants, recruitment and retention, salary support for program leadership and salary support for staff. The Thoracic Oncology Program seeks to understand the biology of lung cancer and develop more effective methods for prevention, diagnosis, and treatment. The Program is dedicated to the discovery of new basic principles in lung cancer biology with the specific intent of translating these findings into new targeted combination therapies for lung cancer. The mission of this Program is to define persons at risk for lung cancer and to apply leading technology to develop improved methods for accurate risk assessment and early detection.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016042-34
Application #
7944574
Study Section
Subcommittee G - Education (NCI)
Project Start
2009-04-02
Project End
2013-11-30
Budget Start
2009-04-02
Budget End
2009-11-30
Support Year
34
Fiscal Year
2009
Total Cost
$44,106
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Tsang, Eric J; Wu, Benjamin; Zuk, Patricia (2018) MAPK signaling has stage-dependent osteogenic effects on human adipose-derived stem cells in vitro. Connect Tissue Res 59:129-146
Waters, Lynnea R; Ahsan, Fasih M; Wolf, Dane M et al. (2018) Initial B Cell Activation Induces Metabolic Reprogramming and Mitochondrial Remodeling. iScience 5:99-109
Van Dyk, Kathleen; Bower, Julienne E; Crespi, Catherine M et al. (2018) Cognitive function following breast cancer treatment and associations with concurrent symptoms. NPJ Breast Cancer 4:25
Robinett, Ryan A; Guan, Ning; Lux, Anja et al. (2018) Dissecting Fc?R Regulation through a Multivalent Binding Model. Cell Syst 7:41-48.e5
Chin, Chee Jia; Li, Suwen; Corselli, Mirko et al. (2018) Transcriptionally and Functionally Distinct Mesenchymal Subpopulations Are Generated from Human Pluripotent Stem Cells. Stem Cell Reports 10:436-446
Alban, Tyler J; Alvarado, Alvaro G; Sorensen, Mia D et al. (2018) Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis. JCI Insight 3:
Yang, Qing; Fung, Wing K; Li, Gang (2018) Sample size determination for jointly testing a cause-specific hazard and the all-cause hazard in the presence of competing risks. Stat Med 37:1389-1401
Seo, Jai Woong; Tavaré, Richard; Mahakian, Lisa M et al. (2018) CD8+ T-Cell Density Imaging with 64Cu-Labeled Cys-Diabody Informs Immunotherapy Protocols. Clin Cancer Res 24:4976-4987
Ribas, Antoni; Wolchok, Jedd D (2018) Cancer immunotherapy using checkpoint blockade. Science 359:1350-1355
Wang, Hong; Chen, Xiaolin; Li, Gang (2018) Survival Forests with R-Squared Splitting Rules. J Comput Biol 25:388-395

Showing the most recent 10 out of 767 publications